Jupiter Life Line Hospitals Limited IPO

Mainboard

Hospital

Listed On: Sep 18, 2023 at ₹ 973.0(NSE)

₹ 14700 /20 Shares

Check Allotment

Price Summary

Last Closing

1,428.85 (94.4%)

52 Week High

1,653.95

52 Week Low

992.50

Last Update

8-Nov-2024 3:30 PM

Jupiter Life Line Hospitals Limited IPO Details

06 Sep, 2023

Open Date

08 Sep, 2023

Close Date

13 Sep, 2023

Allotment Date

18 Sep, 2023

Listing Date

Issue Price

₹695-735 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Kfin Technologies Limited

List Price

973.0(NSE)

Listing Date

2023-09-18

Market Lot

Retail : 20 Shares (₹14,700/-)
S-HNI : 280 Shares (₹2,05,800/-)
B-HNI : 1,380 Shares (₹10,14,300/-)

Lead Manager

ICICI Securities Limited
Nuvama Wealth Management Limited
Jm Financial Limited

Issue Size

Total ₹869.08 Cr :
#Fresh Issue : 7,374,163 shares(aggregating up to ₹542.00 Cr) +
#OFS : 4,450,000 shares of ₹10(aggregating up to ₹327.08 Cr)

Retail Portion

35% (Number of Retail Applications: 2,06,923 Approx),
(Number of S-HNI Applications : 2,111 Approx),
(Number of B-HNI Applications : 4,223 Approx)

Subscription

63.71 times

IPO Docs

DRHP RHP ANCHOR

Jupiter Life Line Hospitals Limited IPO Subscription Details

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	2,443,743	1,773,625 1,182,416 591,209	4,138,458	8,355,826
Day 1 - 06-09-23 05:00 PM	0.01 x	1.43 1.23 x 1.83 x	1.10 x	0.87 x
Day 2 - 07-09-23 05:00 PM	1.03 x	6.63 6.65 x 6.59 x	3.07 x	3.27 x
Day 3 - 08-09-23 05:00 PM	187.32 x	34.75 39.24 x 25.77 x	7.71 x	63.71 x

Total No. of Applications: 14,55,252 (Approx)

Retail Subscription on the basis of Applications: 7.03 times

Jupiter Life Line Hospitals Limited Valuations

Earnings Per Share (EPS)

₹13.95/-

P/E Ratio

52.68

RoNW

20.03%

Net Asset Value (NAV) - As on 31.03.23

₹64.39

Jupiter Life Line Hospitals Limited Company Financials All values are in ₹ Cr.

	31-Mar-23	31-Mar-22	31-Mar-21
Assets	985.53	908.70	788.91
Revenue	902.96	737.14	490.27
Profit After Tax	72.91	51.13	-2.30

About The Company

Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.

Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.

According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

	P/B Ratio	P/E Ratio	RoNW	Net Worth
Jupiter Life Line	11.41	66.10	20.03%	902
Apollo Hospitals	11.2	104	13.7%	17,235
Fortis Healthcare	3.35	47.0	7.77%	6,467
Narayana Hrudalaya	9.86	30.6	33.1%	4,725
Max Healthcare	7.59	47.8	16.1%	4,778
Krishna Institute	9.27	45.9	21.3%	2,308
Global Health	7.79	51.1	16.2%	2,850

Jupiter Life Line Hospitals Limited - Promoter(s)

Pre Issue Share Holding: 49.79%

Post Issue Share Holding: 40.91%

Company Promoter(s)

Dr. Ajay Thakker
Dr. Ankit Thakker
Western Medical Solutions LLP

Jupiter Life Line Hospitals Limited IPO - Issue Objectives

Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary
General corporate purposes.

Jupiter Life Line Hospitals Limited IPO - Anchor Investors

Jupiter Life Line Hospitals mops up Rs 260.72 crore via anchor book ahead of IPO.
As many as 39 investors made an investment in the company via anchor book including marquee names like Government of Singapore, Abu Dhabi Investment Authority, Fidelity Funds, Goldman Sachs, Nomura Funds, HSBC Global, Florida Retirement System, and Natixis International Funds.
Domestic investors including SBI Mutual Fund, ICICI Prudential, Nippon Life, HDFC Mutual Fund, Axis Mutual Fund, Aditya Birla Sun Life Trustee, UTI Mutual Fund, Motilal Oswal MF, HDFC Life Insurance, and SBI Life Insurance Company also participated in the anchor book.

Jupiter Life Line Hospitals Limited IPO - FAQs

Ans. Jupiter Life Line Hospitals Limited IPO is a Mainboard IPO. The issue is priced at ₹695-735 per equity share. The minimum order quantity is 20 Shares. The IPO opens on Sep 6, 2023, and closes on Sep 8, 2023. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Jupiter Life Line Hospitals Limited IPO opens on Sep 6, 2023 and closes on Sep 8, 2023.

Ans. The size of Jupiter Life Line Hospitals Limited IPO is Total ₹869.08 Cr : #Fresh Issue : 7,374,163 shares(aggregating up to ₹542.00 Cr) + #OFS : 4,450,000 shares of ₹10(aggregating up to ₹327.08 Cr).

Ans. The IPO price band is set between ₹695-735 per equity share.

Ans. To apply for Jupiter Life Line Hospitals Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Jupiter Life Line Hospitals Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Jupiter Life Line Hospitals Limited IPO is Sep 13, 2023.

Ans. The Jupiter Life Line Hospitals Limited IPO will be listed on Sep 18, 2023.

Ans. Follow the steps to check the allotment status for Jupiter Life Line Hospitals Limited IPO here.